TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) EBITDA (2022 - 2023)

Updated

TFA Therapeutics' EBITDA came in at $68,132 for FY2025, down 71.6% from $240,145 in FY2024.

Analysis

TFA Therapeutics (RAJAF) EBITDA (2022 - 2023) Analysis & Trends

Going back to FY2020, TFA Therapeutics' EBITDA data covers 6 years.

  • EBITDA carries a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
  • The FY2025 figure represents the lowest annual EBITDA since FY2022.
  • Per Business Quant, earlier years put EBITDA at $240,145 in FY2024 (-35.2%), $370,806 in FY2023, -$333,965 in FY2022 and $34,783 in FY2021 (-1.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn 4.76 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn 1.17 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn 844.00 Mn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn 159.00 Mn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn 800.00 Mn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn 383.00 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn 552.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn 128.54 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn 170.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 294,489.00
Dec 31, 2022 -24,656.00
API Access

TFA Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RAJAF&period=max&api_key=YOUR_API_KEY